Orbis Medicines, a cutting-edge drug discovery company headquartered in Copenhagen, has raised €90 million in a Series A funding round, bringing its total funding to €116 million.
Copyright © 2023. Founders Today. All rights reserved
Your go-to source for the latest Startup developments.
Would you like us to send you the latest news from the startup world?